The Power of the Molecular Microbiology Lab

Consolidation of microbiology lab testing services saves costs and improves testing efficiencies

With nearly 70% of clinical decisions now being made on the basis of laboratory diagnostic testing, the power of today’s molecular lab has never been stronger.¹ To further strengthen this position, microbiology labs can look to consolidation as a means to streamline processes, improve productivity and reduce costs to keep pace with changing healthcare economics.

The consolidation of microbiology lab testing services is a cost-saving strategy that eliminates duplication and improves testing efficiencies.² Research suggests that the consolidation of lab services can produce significant cost savings without compromising efficiency or quality of service.³

At Roche, efficiency, patient care, and lab staff satisfaction drive the future. 

The growing incidence of HAIs demonstrates the need for reliable surveillance 

Hospital costs directly related to management of healthcare-associated infections (HAIs) are on the rise and the subject of intense focus for managing quality of care and institutional efficiency. 

In high-income countries alone, the cost of HAIs is estimated to be nearly €7 billion annually.⁴ On top of these financial costs, HAIs can result in:⁴

• Prolonged hospital stays
• Increased resistance of microorganisms to antimicrobials
• Emotional burden for patients and their families
• Increased number of deaths 

Microbiology labs are the first lines of defense for detection of HAIs, unexpected pandemics, and outbreaks. By implementing a reliable surveillance program that rapidly and accurately detects colonized patients, clinical microbiology and infection control can help reduce the worldwide burden and spread of these costly infections.